 | • レポートコード：MRC2102QY3331 • 出版社/出版日：QYResearch / 2021年1月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のバイオマーカー商品化市場について種類別（消耗品、サービス、ソフトウェア）、用途別（腫瘍学、心臓病学、神経学、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・バイオマーカー商品化市場の概要 ・世界の主要地域別バイオマーカー商品化市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のバイオマーカー商品化市場規模2015-2026：種類別（消耗品、サービス、ソフトウェア） ・世界のバイオマーカー商品化市場規模2015-2026：用途別（腫瘍学、心臓病学、神経学、その他） ・バイオマーカー商品化の米国市場規模2015-2020 ・バイオマーカー商品化のヨーロッパ市場規模2015-2020 ・バイオマーカー商品化の中国市場規模2015-2020 ・バイオマーカー商品化の日本市場規模2015-2020 ・バイオマーカー商品化の東南アジア市場規模2015-2020 ・バイオマーカー商品化のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・バイオマーカー商品化の製造コスト分析 ・販売チャネル、流通業者、顧客 ・バイオマーカー商品化の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Commercializing Biomarkers Market
The global Commercializing Biomarkers market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Commercializing Biomarkers Scope and Market Size
The global Commercializing Biomarkers market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Commercializing Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Commercializing Biomarkers market is segmented into
Consumables
Services
Software
Segment by Application, the Commercializing Biomarkers market is segmented into
Oncology
Cardiology
Neurology
Others
The Commercializing Biomarkers market is analysed and market size information is provided by regions (countries). Segment by Application, the Commercializing Biomarkers market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Commercializing Biomarkers Market Share Analysis
Commercializing Biomarkers market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Commercializing Biomarkers business, the date to enter into the Commercializing Biomarkers market, Commercializing Biomarkers product introduction, recent developments, etc.
The major vendors covered:
Roche
Dako (Agilent Technologies)
Merck
BD
Abbott
Genesys Biolabs (20/20GeneSystems)
Affymetrix
Agendia
ALMAC
Arrayit
Biocartic
BG Medicine
KEGG EXPRESSION Database
Thermo Fisher
BGI
1 Commercializing Biomarkers Market Overview
1.1 Commercializing Biomarkers Product Scope
1.2 Commercializing Biomarkers Segment by Type
1.2.1 Global Commercializing Biomarkers Sales by Type (2020-2026)
1.2.2 Consumables
1.2.3 Services
1.2.4 Software
1.3 Commercializing Biomarkers Segment by Application
1.3.1 Global Commercializing Biomarkers Sales Comparison by Application (2020-2026)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Neurology
1.3.5 Others
1.4 Commercializing Biomarkers Market Estimates and Forecasts (2015-2026)
1.4.1 Global Commercializing Biomarkers Sales Growth Rate (2015-2026)
1.4.2 Global Commercializing Biomarkers Revenue and Growth Rate (2015-2026)
1.4.3 Global Commercializing Biomarkers Price Trends (2015-2026)
2 Commercializing Biomarkers Estimate and Forecast by Region
2.1 Global Commercializing Biomarkers Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Commercializing Biomarkers Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Commercializing Biomarkers Sales Market Share by Region (2015-2020)
2.2.2 Global Commercializing Biomarkers Revenue Market Share by Region (2015-2020)
2.3 Global Commercializing Biomarkers Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Commercializing Biomarkers Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Commercializing Biomarkers Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Commercializing Biomarkers Estimates and Projections (2015-2026)
2.4.2 Europe Commercializing Biomarkers Estimates and Projections (2015-2026)
2.4.3 China Commercializing Biomarkers Estimates and Projections (2015-2026)
2.4.4 Japan Commercializing Biomarkers Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Commercializing Biomarkers Estimates and Projections (2015-2026)
2.4.6 India Commercializing Biomarkers Estimates and Projections (2015-2026)
3 Global Commercializing Biomarkers Competition Landscape by Players
3.1 Global Top Commercializing Biomarkers Players by Sales (2015-2020)
3.2 Global Top Commercializing Biomarkers Players by Revenue (2015-2020)
3.3 Global Commercializing Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Commercializing Biomarkers as of 2019)
3.4 Global Commercializing Biomarkers Average Price by Company (2015-2020)
3.5 Manufacturers Commercializing Biomarkers Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Commercializing Biomarkers Players (Opinion Leaders)
4 Global Commercializing Biomarkers Market Size by Type
4.1 Global Commercializing Biomarkers Historic Market Review by Type (2015-2020)
4.1.1 Global Commercializing Biomarkers Sales Market Share by Type (2015-2020)
4.1.2 Global Commercializing Biomarkers Revenue Market Share by Type (2015-2020)
4.1.3 Global Commercializing Biomarkers Price by Type (2015-2020)
4.2 Global Commercializing Biomarkers Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Commercializing Biomarkers Sales Forecast by Type (2021-2026)
4.2.2 Global Commercializing Biomarkers Revenue Forecast by Type (2021-2026)
4.2.3 Global Commercializing Biomarkers Price Forecast by Type (2021-2026)
5 Global Commercializing Biomarkers Market Size by Application
5.1 Global Commercializing Biomarkers Historic Market Review by Application (2015-2020)
5.1.1 Global Commercializing Biomarkers Sales Market Share by Application (2015-2020)
5.1.2 Global Commercializing Biomarkers Revenue Market Share by Application (2015-2020)
5.1.3 Global Commercializing Biomarkers Price by Application (2015-2020)
5.2 Global Commercializing Biomarkers Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Commercializing Biomarkers Sales Forecast by Application (2021-2026)
5.2.2 Global Commercializing Biomarkers Revenue Forecast by Application (2021-2026)
5.2.3 Global Commercializing Biomarkers Price Forecast by Application (2021-2026)
6 United States Commercializing Biomarkers Market Facts & Figures
6.1 United States Commercializing Biomarkers Sales Market Share by Company (2015-2020)
6.2 United States Commercializing Biomarkers Sales Market Share by Type (2015-2020)
6.3 United States Commercializing Biomarkers Sales Market Share by Application (2015-2020)
7 Europe Commercializing Biomarkers Market Facts & Figures
7.1 Europe Commercializing Biomarkers Sales Market Share by Company (2015-2020)
7.2 Europe Commercializing Biomarkers Sales Market Share by Type (2015-2020)
7.3 Europe Commercializing Biomarkers Sales Market Share by Application (2015-2020)
8 China Commercializing Biomarkers Market Facts & Figures
8.1 China Commercializing Biomarkers Sales Market Share by Company (2015-2020)
8.2 China Commercializing Biomarkers Sales Market Share by Type (2015-2020)
8.3 China Commercializing Biomarkers Sales Market Share by Application (2015-2020)
9 Japan Commercializing Biomarkers Market Facts & Figures
9.1 Japan Commercializing Biomarkers Sales Market Share by Company (3015-3030)
9.2 Japan Commercializing Biomarkers Sales Market Share by Type (2015-2020)
9.3 Japan Commercializing Biomarkers Sales Market Share by Application (2015-2020)
10 Southeast Asia Commercializing Biomarkers Market Facts & Figures
10.1 Southeast Asia Commercializing Biomarkers Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Commercializing Biomarkers Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Commercializing Biomarkers Sales Market Share by Application (2015-2020)
11 India Commercializing Biomarkers Market Facts & Figures
11.1 India Commercializing Biomarkers Sales Market Share by Company (2015-2020)
11.2 India Commercializing Biomarkers Sales Market Share by Type (2015-2020)
11.3 India Commercializing Biomarkers Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Commercializing Biomarkers Business
12.1 Roche
12.1.1 Roche Corporation Information
12.1.2 Roche Business Overview
12.1.3 Roche Commercializing Biomarkers Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Roche Commercializing Biomarkers Products Offered
12.1.5 Roche Recent Development
12.2 Dako (Agilent Technologies)
12.2.1 Dako (Agilent Technologies) Corporation Information
12.2.2 Dako (Agilent Technologies) Business Overview
12.2.3 Dako (Agilent Technologies) Commercializing Biomarkers Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Dako (Agilent Technologies) Commercializing Biomarkers Products Offered
12.2.5 Dako (Agilent Technologies) Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Business Overview
12.3.3 Merck Commercializing Biomarkers Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merck Commercializing Biomarkers Products Offered
12.3.5 Merck Recent Development
12.4 BD
12.4.1 BD Corporation Information
12.4.2 BD Business Overview
12.4.3 BD Commercializing Biomarkers Sales, Revenue and Gross Margin (2015-2020)
12.4.4 BD Commercializing Biomarkers Products Offered
12.4.5 BD Recent Development
12.5 Abbott
12.5.1 Abbott Corporation Information
12.5.2 Abbott Business Overview
12.5.3 Abbott Commercializing Biomarkers Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Abbott Commercializing Biomarkers Products Offered
12.5.5 Abbott Recent Development
12.6 Genesys Biolabs (20/20GeneSystems)
12.6.1 Genesys Biolabs (20/20GeneSystems) Corporation Information
12.6.2 Genesys Biolabs (20/20GeneSystems) Business Overview
12.6.3 Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers Products Offered
12.6.5 Genesys Biolabs (20/20GeneSystems) Recent Development
12.7 Affymetrix
12.7.1 Affymetrix Corporation Information
12.7.2 Affymetrix Business Overview
12.7.3 Affymetrix Commercializing Biomarkers Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Affymetrix Commercializing Biomarkers Products Offered
12.7.5 Affymetrix Recent Development
12.8 Agendia
12.8.1 Agendia Corporation Information
12.8.2 Agendia Business Overview
12.8.3 Agendia Commercializing Biomarkers Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Agendia Commercializing Biomarkers Products Offered
12.8.5 Agendia Recent Development
12.9 ALMAC
12.9.1 ALMAC Corporation Information
12.9.2 ALMAC Business Overview
12.9.3 ALMAC Commercializing Biomarkers Sales, Revenue and Gross Margin (2015-2020)
12.9.4 ALMAC Commercializing Biomarkers Products Offered
12.9.5 ALMAC Recent Development
12.10 Arrayit
12.10.1 Arrayit Corporation Information
12.10.2 Arrayit Business Overview
12.10.3 Arrayit Commercializing Biomarkers Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Arrayit Commercializing Biomarkers Products Offered
12.10.5 Arrayit Recent Development
12.11 Biocartic
12.11.1 Biocartic Corporation Information
12.11.2 Biocartic Business Overview
12.11.3 Biocartic Commercializing Biomarkers Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Biocartic Commercializing Biomarkers Products Offered
12.11.5 Biocartic Recent Development
12.12 BG Medicine
12.12.1 BG Medicine Corporation Information
12.12.2 BG Medicine Business Overview
12.12.3 BG Medicine Commercializing Biomarkers Sales, Revenue and Gross Margin (2015-2020)
12.12.4 BG Medicine Commercializing Biomarkers Products Offered
12.12.5 BG Medicine Recent Development
12.13 KEGG EXPRESSION Database
12.13.1 KEGG EXPRESSION Database Corporation Information
12.13.2 KEGG EXPRESSION Database Business Overview
12.13.3 KEGG EXPRESSION Database Commercializing Biomarkers Sales, Revenue and Gross Margin (2015-2020)
12.13.4 KEGG EXPRESSION Database Commercializing Biomarkers Products Offered
12.13.5 KEGG EXPRESSION Database Recent Development
12.14 Thermo Fisher
12.14.1 Thermo Fisher Corporation Information
12.14.2 Thermo Fisher Business Overview
12.14.3 Thermo Fisher Commercializing Biomarkers Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Thermo Fisher Commercializing Biomarkers Products Offered
12.14.5 Thermo Fisher Recent Development
12.15 BGI
12.15.1 BGI Corporation Information
12.15.2 BGI Business Overview
12.15.3 BGI Commercializing Biomarkers Sales, Revenue and Gross Margin (2015-2020)
12.15.4 BGI Commercializing Biomarkers Products Offered
12.15.5 BGI Recent Development
13 Commercializing Biomarkers Manufacturing Cost Analysis
13.1 Commercializing Biomarkers Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Commercializing Biomarkers
13.4 Commercializing Biomarkers Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Commercializing Biomarkers Distributors List
14.3 Commercializing Biomarkers Customers
15 Market Dynamics
15.1 Commercializing Biomarkers Market Trends
15.2 Commercializing Biomarkers Opportunities and Drivers
15.3 Commercializing Biomarkers Market Challenges
15.4 Commercializing Biomarkers Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Commercializing Biomarkers Sales (K MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Commercializing Biomarkers Sales (K MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Commercializing Biomarkers Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Commercializing Biomarkers Sales (K MT) by Region (2015-2020)
Table 5. Global Commercializing Biomarkers Sales Market Share by Region (2015-2020)
Table 6. Global Commercializing Biomarkers Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Commercializing Biomarkers Revenue Share by Region (2015-2020)
Table 8. Global Commercializing Biomarkers Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Commercializing Biomarkers Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Commercializing Biomarkers Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Commercializing Biomarkers Revenue Share Forecast by Region (2021-2026)
Table 12. Global Commercializing Biomarkers (K MT) of Key Companies (2015-2020)
Table 13. Global Commercializing Biomarkers Sales Share by Company (2015-2020)
Table 14. Global Commercializing Biomarkers Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Commercializing Biomarkers Revenue Share by Company (2015-2020)
Table 16. Global Commercializing Biomarkers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Commercializing Biomarkers as of 2019)
Table 17. Global Commercializing Biomarkers Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Commercializing Biomarkers Manufacturing Sites and Area Served
Table 19. Manufacturers Commercializing Biomarkers Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Commercializing Biomarkers Players
Table 22. Global Commercializing Biomarkers Sales (K MT) by Type (2015-2020)
Table 23. Global Commercializing Biomarkers Sales Share by Type (2015-2020)
Table 24. Global Commercializing Biomarkers Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Commercializing Biomarkers Price (K MT) by Type (2015-2020)
Table 26. Global Commercializing Biomarkers Sales Share by Type (2021-2026)
Table 27. Global Commercializing Biomarkers Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Commercializing Biomarkers Revenue Share by Type (2021-2026)
Table 29. Global Commercializing Biomarkers Price (K MT) by Type (2021-2026)
Table 30. Global Commercializing Biomarkers Sales (K MT) by Application (2015-2020)
Table 31. Global Commercializing Biomarkers Sales Share by Application (2015-2020)
Table 32. Global Commercializing Biomarkers Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Commercializing Biomarkers Price (K MT) by Application (2015-2020)
Table 34. Global Commercializing Biomarkers Sales (K MT) by Application (2021-2026)
Table 35. Global Commercializing Biomarkers Sales Share by Application (2021-2026)
Table 36. Global Commercializing Biomarkers Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Commercializing Biomarkers Revenue Share by Application (2021-2026)
Table 38. Global Commercializing Biomarkers Price (K MT) by Application (2021-2026)
Table 39. United States Commercializing Biomarkers Sales (K MT) by Company (2015-2020)
Table 40. United States Commercializing Biomarkers Sales Market Share by Company (2015-2020)
Table 41. United States Commercializing Biomarkers Sales (K MT) by Type (2015-2020)
Table 42. United States Commercializing Biomarkers Sales Market Share by Type (2015-2020)
Table 43. United States Commercializing Biomarkers Sales (K MT) by Application (2015-2020)
Table 44. United States Commercializing Biomarkers Sales Market Share by Application (2015-2020)
Table 45. Europe Commercializing Biomarkers Sales (K MT) by Company (2015-2020)
Table 46. Europe Commercializing Biomarkers Sales Market Share by Company (2015-2020)
Table 47. Europe Commercializing Biomarkers Sales (K MT) by Type (2015-2020)
Table 48. Europe Commercializing Biomarkers Sales Market Share by Type (2015-2020)
Table 49. Europe Commercializing Biomarkers Sales (K MT) by Application (2015-2020)
Table 50. Europe Commercializing Biomarkers Sales Market Share by Type (2015-2020)
Table 51. China Commercializing Biomarkers Sales (K MT) by Company (2015-2020)
Table 52. China Commercializing Biomarkers Sales Market Share by Company (2015-2020)
Table 53. China Commercializing Biomarkers Sales (K MT) by Type (2015-2020)
Table 54. China Commercializing Biomarkers Sales Market Share by Type (2015-2020)
Table 55. China Commercializing Biomarkers Sales (K MT) by Application (2015-2020)
Table 56. China Commercializing Biomarkers Sales Market Share by Application (2015-2020)
Table 57. Japan Commercializing Biomarkers Sales (K MT) by Company (2015-2020)
Table 58. Japan Commercializing Biomarkers Sales Market Share by Company (2015-2020)
Table 59. Japan Commercializing Biomarkers Sales (K MT) by Type (2015-2020)
Table 60. Japan Commercializing Biomarkers Sales Market Share by Type (2015-2020)
Table 61. Japan Commercializing Biomarkers Sales (K MT) by Application (2015-2020)
Table 62. Japan Commercializing Biomarkers Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Commercializing Biomarkers Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Commercializing Biomarkers Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Commercializing Biomarkers Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Commercializing Biomarkers Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Commercializing Biomarkers Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Commercializing Biomarkers Sales Market Share by Application (2015-2020)
Table 69. India Commercializing Biomarkers Sales (K MT) by Company (2015-2020)
Table 70. India Commercializing Biomarkers Sales Market Share by Company (2015-2020)
Table 71. India Commercializing Biomarkers Sales (K MT) by Type (2015-2020)
Table 72. India Commercializing Biomarkers Sales Market Share by Type (2015-2020)
Table 73. India Commercializing Biomarkers Sales (K MT) by Application (2015-2020)
Table 74. India Commercializing Biomarkers Sales Market Share by Application (2015-2020)
Table 75. Roche Corporation Information
Table 76. Roche Description and Business Overview
Table 77. Roche Commercializing Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Roche Commercializing Biomarkers Product
Table 79. Roche Recent Development
Table 80. Dako (Agilent Technologies) Corporation Information
Table 81. Dako (Agilent Technologies) Description and Business Overview
Table 82. Dako (Agilent Technologies) Commercializing Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Dako (Agilent Technologies) Commercializing Biomarkers Product
Table 84. Dako (Agilent Technologies) Recent Development
Table 85. Merck Corporation Information
Table 86. Merck Description and Business Overview
Table 87. Merck Commercializing Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Merck Commercializing Biomarkers Product
Table 89. Merck Recent Development
Table 90. BD Corporation Information
Table 91. BD Description and Business Overview
Table 92. BD Commercializing Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. BD Commercializing Biomarkers Product
Table 94. BD Recent Development
Table 95. Abbott Corporation Information
Table 96. Abbott Description and Business Overview
Table 97. Abbott Commercializing Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Abbott Commercializing Biomarkers Product
Table 99. Abbott Recent Development
Table 100. Genesys Biolabs (20/20GeneSystems) Corporation Information
Table 101. Genesys Biolabs (20/20GeneSystems) Description and Business Overview
Table 102. Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers Product
Table 104. Genesys Biolabs (20/20GeneSystems) Recent Development
Table 105. Affymetrix Corporation Information
Table 106. Affymetrix Description and Business Overview
Table 107. Affymetrix Commercializing Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Affymetrix Commercializing Biomarkers Product
Table 109. Affymetrix Recent Development
Table 110. Agendia Corporation Information
Table 111. Agendia Commercializing Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Agendia Description and Business Overview
Table 113. Agendia Commercializing Biomarkers Product
Table 114. Agendia Recent Development
Table 115. ALMAC Corporation Information
Table 116. ALMAC Commercializing Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. ALMAC Description and Business Overview
Table 118. ALMAC Commercializing Biomarkers Product
Table 119. ALMAC Recent Development
Table 120. Arrayit Corporation Information
Table 121. Arrayit Description and Business Overview
Table 122. Arrayit Commercializing Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Arrayit Commercializing Biomarkers Product
Table 124. Arrayit Recent Development
Table 125. Biocartic Corporation Information
Table 126. Biocartic Description and Business Overview
Table 127. Biocartic Commercializing Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Biocartic Commercializing Biomarkers Product
Table 129. Biocartic Recent Development
Table 130. BG Medicine Corporation Information
Table 131. BG Medicine Description and Business Overview
Table 132. BG Medicine Commercializing Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. BG Medicine Commercializing Biomarkers Product
Table 134. BG Medicine Recent Development
Table 135. KEGG EXPRESSION Database Corporation Information
Table 136. KEGG EXPRESSION Database Description and Business Overview
Table 137. KEGG EXPRESSION Database Commercializing Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. KEGG EXPRESSION Database Commercializing Biomarkers Product
Table 139. KEGG EXPRESSION Database Recent Development
Table 140. Thermo Fisher Corporation Information
Table 141. Thermo Fisher Description and Business Overview
Table 142. Thermo Fisher Commercializing Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Thermo Fisher Commercializing Biomarkers Product
Table 144. Thermo Fisher Recent Development
Table 145. BGI Corporation Information
Table 146. BGI Description and Business Overview
Table 147. BGI Commercializing Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. BGI Commercializing Biomarkers Product
Table 149. BGI Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Commercializing Biomarkers Distributors List
Table 153. Commercializing Biomarkers Customers List
Table 154. Commercializing Biomarkers Market Key Trends
Table 155. Commercializing Biomarkers Key Opportunities and Drivers
Table 156. Commercializing Biomarkers Market Challenges
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Commercializing Biomarkers Product Picture
Figure 2. Global Commercializing Biomarkers Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Commercializing Biomarkers Market Share by Application in 2020 & 2026
Figure 6. Oncology Examples
Figure 7. Cardiology Examples
Figure 8. Neurology Examples
Figure 9. Others Examples
Figure 10. Global Commercializing Biomarkers Sales (K MT) Growth Rate (2015-2026)
Figure 11. Global Commercializing Biomarkers Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Commercializing Biomarkers Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 13. Global Commercializing Biomarkers Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Commercializing Biomarkers Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Commercializing Biomarkers Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Commercializing Biomarkers Sales (K MT) Growth Rate (2015-2026)
Figure 17. Europe Commercializing Biomarkers Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Commercializing Biomarkers Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Commercializing Biomarkers Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Commercializing Biomarkers Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Commercializing Biomarkers Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Commercializing Biomarkers Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Commercializing Biomarkers Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Commercializing Biomarkers Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Commercializing Biomarkers Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Commercializing Biomarkers Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Commercializing Biomarkers Players Market Share by Revenue in Commercializing Biomarkers 2015 & 2019
Figure 28. Commercializing Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Commercializing Biomarkers Revenue Share by Type (2015-2020)
Figure 30. Global Commercializing Biomarkers Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Commercializing Biomarkers Revenue Share by Application (2015-2020)
Figure 32. Global Commercializing Biomarkers Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Commercializing Biomarkers Sales Market Share by Type in 2019
Figure 34. United States Commercializing Biomarkers Sales Market Share by Type in 2019
Figure 35. Europe Commercializing Biomarkers Sales Market Share by Company in 2019
Figure 36. Europe Commercializing Biomarkers Sales Market Share by Type in 2019
Figure 37. Europe Commercializing Biomarkers Sales Market Share by Application in 2019
Figure 38. China Commercializing Biomarkers Sales Market Share by Company in 2019
Figure 39. China Commercializing Biomarkers Sales Market Share by Type in 2019
Figure 40. China Commercializing Biomarkers Sales Market Share by Application in 2019
Figure 41. Japan Commercializing Biomarkers Sales Market Share by Company in 2019
Figure 42. Japan Commercializing Biomarkers Sales Market Share by Type in 2019
Figure 43. Japan Commercializing Biomarkers Sales Market Share by Application in 2019
Figure 44. Southeast Asia Commercializing Biomarkers Sales Market Share by Company in 2019
Figure 45. Southeast Asia Commercializing Biomarkers Sales Market Share by Type in 2019
Figure 46. Southeast Asia Commercializing Biomarkers Sales Market Share by Application in 2019
Figure 47. India Commercializing Biomarkers Sales Market Share by Company in 2019
Figure 48. India Commercializing Biomarkers Sales Market Share by Type in 2019
Figure 49. India Commercializing Biomarkers Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Commercializing Biomarkers
Figure 52. Manufacturing Process Analysis of Commercializing Biomarkers
Figure 53. Commercializing Biomarkers Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
神経学的バイオマーカーの世界市場レポート2020 A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood gluco…- 神経学EMRソフトウェアの世界市場レポート2020 Market Analysis and Insights: Global Neurology EMR Software Market The global Neurology EMR Software market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Neurology EMR Software Scope and Market Size The global Neurology EMR …
- 心臓病電極の世界市場レポート2020 Electrocardiography is the process of recording the electrical activity of the heart over a period of time using electrodes placed on the skin. These electrodes detect the tiny electrical changes on the skin that arise from the heart muscle's electrophysiologic pattern of depolarizing and repolarizi…
- インターベンショナル心臓病学・末梢血管装置の世界市場レポート2020 Market Analysis and Insights: Global Interventional Cardiology and Peripheral Vascular Devices Market The global Interventional Cardiology and Peripheral Vascular Devices market size is projected to reach US$ 24270 million by 2026, from US$ 20180 million in 2020, at a CAGR of 3.1% during 2021-2026. …
- 改装心臓血管・心臓病学機器の世界市場レポート2020 Market Analysis and Insights: Global Refurbished Cardiovascular and Cardiology Equipment Market The global Refurbished Cardiovascular and Cardiology Equipment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Refurbished …